Key result
Oral amino acid supplementation in chronic HF is linked to ~14% higher peak VO2.
Why the study?
Amino acid availability is reduced in patients with heart failure, leading to metabolic abnormalities and reduced functional capacity, but the effects of oral amino acid supplementation on exercise tolerance and quality of life are unclear.
Does oral amino acid supplementation improve exercise tolerance in patients with chronic stable heart failure?
Population
13 patients with chronic stable HF, NYHA class II/III, EF <45%
Comparison
Oral supplementation with essential and semi-essential amino acids for three months vs baseline
Design
Cohort study
Follow-up
Three months
Authors
Loading...
Hypothesis-generating for amino acid supplementation in chronic HF; randomized trials needed before clinical adoption.
Does oral amino acid supplementation improve exercise tolerance in patients with chronic stable heart failure?
Absolute Event Rate: 16.8% vs 14.8%
p-value: p=0.008
Oral amino acid supplementation for three months in patients with chronic stable heart failure improved exercise tolerance but did not significantly change quality of life.
Lombardi et al. (2014) studied chronic stable heart failure (n=13). Oral amino acid supplements vs. Baseline was evaluated on exercise tolerance (peak VO2) (p=0.008). Oral amino acid supplementation for 3 months in chronic heart failure significantly improved peak VO2 (14.8 vs 16.8 mL/min/kg; P=0.008) and 6MWT distance (439.1 vs 474.2 m; P=0.006).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: